Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - solifenacin succinate 10 mg - eq. solifenacin 7,5 mg - film-coated tablet - 10 mg - solifenacin succinate 10 mg - solifenacin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - solifenacin succinate 5 mg - eq. solifenacin 3,8 mg - film-coated tablet - 5 mg - solifenacin succinate 5 mg - solifenacin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - solifenacin succinate 10 mg - eq. solifenacin 7,5 mg - film-coated tablet - 10 mg - solifenacin succinate 10 mg - solifenacin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - solifenacin succinate 5 mg - eq. solifenacin 3,8 mg - film-coated tablet - 5 mg - solifenacin succinate 5 mg - solifenacin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - solifenacin succinate 10 mg - eq. solifenacin 7,5 mg - film-coated tablet - 10 mg - solifenacin succinate 10 mg - solifenacin

Canada - English - Health Canada

mantra pharma inc - solifenacin succinate - tablet - 5mg - solifenacin succinate 5mg

Canada - English - Health Canada

mantra pharma inc - solifenacin succinate - tablet - 10mg - solifenacin succinate 10mg

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - solifenacin succinate - tablets - solifenacin succinate 10 mg - solifenacin - for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - solifenacin succinate - tablets - solifenacin succinate 5 mg - solifenacin - for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - solifenacin succinate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.